Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

CD20+inflammatory T-cells are present in blood and brain of multiple sclerosis patients and can be selectively targeted for apoptotic elimination.
Behavioral experiences as drivers of oligodendrocyte lineage dynamics and myelin plasticity.
A subject-specific framework for in vivo myeloarchitectonic analysis using high resolution quantitative MRI.
Sural sparing in Guillain-Barré syndrome subtypes: a reappraisal with historical and recent definitions.
Polymorphism of the osteopontin gene and clinical course of multiple sclerosis in the Polish population.
[Hypomyelination with atrophy of the basal ganglia and cerebellum. Contribution of two new cases to a recently reported entity].
Investigation of Simvastatin in Secondary Progressive Multiple Sclerosis (MS-STAT)
Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.
Impaired Cerebrovascular Reactivity in Multiple Sclerosis.
Protein kinase C polymorphisms and vitamin D levels in multiple sclerosis.
Benign-onset acute disseminated encephalomyelitis: a report on two cases.
Plasma levels of neuron specific enolase quantify the extent of neuronal injury in murine models of ischemic stroke and multiple sclerosis.
Glutamate signaling in benign and malignant disorders: current status, future perspectives, and therapeutic implications.
Second line use of Fingolimod is as effective as Natalizumab in a German out-patient RRMS-cohort.
Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Reliability of the Swedish version of the Exercise Self-Efficacy Scale (S-ESES): a test-retest study in adults with neurological disease.
Naringenin Suppresses Neuroinflammatory Responses Through Inducing Suppressor of Cytokine Signaling 3 Expression.
Nuclear export inhibitors avert progression in preclinical models of inflammatory demyelination.
Another promising oral agent for multiple sclerosis.
An early British case of neuromyelitis optica (1850).
Cerebral hypoperfusion in multiple sclerosis is reversible and mediated by endothelin-1.
Reimbursement and market access of multiple sclerosis products in the United States.
Disruption of Myelin Leads to Ectopic Expression of KV1.1 Channels with Abnormal Conductivity of Optic Nerve Axons in a Cuprizone-Induced Model of Demyelination.
Obesity and HLA in multiple sclerosis: Weighty matters.

Pages